LivaNova (LIVN) Return on Capital Employed (2016 - 2026)
LivaNova (LIVN) posted Return on Capital Employed of 10.69% for Q1 2026, down 4.92% sequentially from 11.24% in Q4 2025, and up 167.0% YoY from 4.0% in Q1 2025.
LivaNova (LIVN) Return on Capital Employed (2016 - 2026) Analysis & Trends
LivaNova has reported Return on Capital Employed for 11 years, with the latest figure at 10.69% in Q1 2026.
- Quarterly Return on Capital Employed rose 167.0% year-over-year to 10.69% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.69% (up 167.0% YoY) and the FY2025 annual result came in at 11.41%, up 519.0% from the prior year.
- Return on Capital Employed declined to 10.69% in Q1 2026 per LIVN's latest filing, from 11.24% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 11.37% in Q3 2025 and troughed at 5.07% in Q2 2023.
- A 5-year average of 2.4% and a median of 0.72% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed jumped 2167 bps in 2022, then sank 897 bps in 2023.
- Over 5 years, Return on Capital Employed stood at 3.92% in 2022, then rose by 15 bps to 3.35% in 2023, then soared by 282 bps to 6.08% in 2024, then jumped by 85 bps to 11.24% in 2025, then declined by 5 bps to 10.69% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 10.69%, 11.24%, and 11.37% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 12.08% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 10.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.02% |
| Mar 31, 2026 | 10.69% |
| Dec 31, 2025 | 11.24% |
| Sep 30, 2025 | 11.37% |
| Jun 30, 2025 | 10.29% |
| Mar 31, 2025 | 9.01% |
| Dec 31, 2024 | 6.08% |
| Sep 30, 2024 | 0.30% |
| Jun 30, 2024 | -2.00% |
| Mar 31, 2024 | -2.36% |
| Dec 31, 2023 | -3.35% |
| Sep 30, 2023 | 1.64% |
| Jun 30, 2023 | -5.07% |
| Mar 31, 2023 | -4.48% |
| Dec 31, 2022 | -3.92% |
| Sep 30, 2022 | -3.32% |
| Jun 30, 2022 | 3.90% |
| Mar 31, 2022 | 0.72% |
| Dec 31, 2021 | -0.05% |
| Sep 30, 2021 | -16.73% |